PI3K/Akt activity has variable cell-specific effects on expression of HIF target genes, CA9 and VEGF, in human cancer cell lines

Cancer Letters

Volumn 282, Issue 1, 2009, Pages 109-115

  Shafee, Norazizah ^a,b   Kaluz, Stefan ^b   Ru, Ning ^b   Stanbridge, Eric J ^b  

^a UNIVERSITY PUTRA MALAYSIA   (Malaysia)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

CAIX; HIF; Hypoxia; PI3K Akt; VEGF

Indexed keywords

CARBONATE DEHYDRATASE IX; HYPOXIA INDUCIBLE FACTOR; N RAS PROTEIN; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; RAS PROTEIN; UNCLASSIFIED DRUG; VASCULOTROPIN;

ALLELE; ARTICLE; CANCER CELL; CANCER CELL CULTURE; CONTROLLED STUDY; ENZYME ACTIVITY; EPIGENETICS; FIBROSARCOMA; GENE ACTIVATION; GENE EXPRESSION; GENE FUNCTION; GENE TARGETING; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; UPREGULATION;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANTIGENS, NEOPLASM; CARBONIC ANHYDRASES; CELL LINE, TUMOR; DNA PRIMERS; FIBROSARCOMA; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, RAS; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; OXYGEN CONSUMPTION; PROMOTER REGIONS, GENETIC; PROTO-ONCOGENE PROTEINS C-AKT; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRANSFECTION; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 67649395578     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2009.03.004     Document Type: Article

References (37)

1. Smith T.G., Robbins P.A., and Ratcliffe P.J. The human side of hypoxia-inducible factor. Br. J. Haematol. 141 (2008) 325-334
2. Chan D.A., Sutphin P.D., Yen S.E., and Giaccia A.J. Coordinate regulation of the oxygen-dependent degradation domains of hypoxia-inducible factor 1 alpha. Mol. Cell. Biol. 25 (2005) 6415-6426
3. 2 sensing. Science 292 (2001) 464-468
4. 2-regulated prolyl hydroxylation. Science 292 (2001) 468-724
5. Arany Z., Huang L.E., Eckner R., Bhattacharya S., Jiang C., Goldberg M.A., Bunn H.F., and Livingston D.M. An essential role for p300/CBP in the cellular response to hypoxia. Proc. Natl. Acad. Sci. USA 93 (1996) 12969-12973
6. 2 homeostasis by hypoxia inducible factor 1. Annu. Rev. Cell Dev. Biol. 15 (1999) 551-578
7. Jiang B.H., Jiang G., Zheng J.Z., Lu Z., Hunter T., and Vogt P.K. Phosphatidylinositol 3-kinase signaling controls levels of hypoxia-inducible factor. Cell Growth Differ. 12 (2001) 363-369
8. Semenza G.L. Targeting HIF-1 for cancer therapy. Nat. Rev. Cancer 3 (2003) 721-732
9. Pore N., Jiang Z., Shu H.K., Bernhard E., Kao G.D., and Maity A. Akt1 activation can augment hypoxia-inducible factor-1alpha expression by increasing protein translation through a mammalian target of rapamycin-independent pathway. Mol. Cancer Res. 4 (2006) 471-479
10. Jiang B.H., and Liu L.Z. AKT signaling in regulating angiogenesis. Curr. Cancer Drug Targets 8 (2008) 19-26
11. Chalhoub N., and Baker S.J. PTEN and the PI3-Kinase Pathway in Cancer. Annu. Rev. Pathol. (2008) Epub ahead of print
12. Jiang B.H., Zheng J.Z., Aoki M., and Vogt P.K. Phosphatidylinositol 3-kinase signaling mediates angiogenesis and expression of vascular endothelial growth factor in endothelial cells. Proc. Natl. Acad. Sci. USA 97 (2000) 1749-1753
13. Zundel W., Schindler C., Haas-Kogan D., Koong A., Kaper F., Chen E., Gottschalk A.R., Ryan H.E., Johnson R.S., Jefferson A.B., Stokoe D., and Giaccia A.J. Loss of PTEN facilitates HIF-1-mediated gene expression. Genes Dev. 14 (2000) 391-396
14. Hudson C.C., Liu M., Chiang G.G., Otterness D.M., Loomis D.C., Kaper F., Giaccia A.J., and Abraham R.T. Regulation of hypoxia-inducible factor 1 expression and function by the mammalian target of rapamycin. Mol. Cell. Biol. 22 (2002) 7004-7014
15. Brugarolas J.B., Vazquez F., Reddy A., Sellers W.R., and Kaelin W.G. TSC2 regulates VEGF through mTOR-dependent and -independent pathways. Cancer Cell 4 (2003) 147-158
16. Alvarez-Tejado M., Alfranca A., Aragones J., Vara A., Landazuri M.O., and del Peso L. Lack of evidence for the involvement of the phosphoinositide 3-kinase/Akt pathway in the activation of hypoxia-inducible factors by low oxygen tension. J. Biol. Chem. 277 (2002) 13508-13517
17. Arsham A.M., Plas D.R., Thompson C.B., and Simon M.C. PI3K/Akt signaling is neither required for hypoxic stabilization of HIF-1 nor sufficient for HIF-1-dependent target gene transcription. J. Biol. Chem. 277 (2002) 15162-15170
18. Gupta S., Plattner R., Der C.J., and Stanbridge E.J. Dissection of Ras-dependent signaling pathways controlling aggressive tumor growth of human fibrosarcoma cells: evidence for a potential novel pathway. Mol. Cell. Biol. 20 (2000) 9294-9306
19. Gupta S., Stuffrein S., Plattner R., Tencati M., Gray C., Whang Y.E., and Stanbridge E.J. Role of phosphoinositide 3-kinase in the aggressive tumor growth of HT1080 human fibrosarcoma cells. Mol. Cell. Biol. 21 (2001) 5846-5856
20. Plattner R., Anderson M.J., Sato K.Y., Fasching C.L., Der C.J., and Stanbridge E.J. Loss of oncogenic ras expression does not correlate with loss of tumorigenicity in human cells. Proc. Natl. Acad. Sci. USA 93 (1996) 6665-6670
21. Kaluz S., Kaluzová M., Chrastina A., Olive P.L., Pastoreková S., Pastorek J., Lerman M.I., and Stanbridge E.J. Lowered oxygen tension induces expression of the hypoxia marker MN/carbonic anhydrase IX in the absence of hypoxia-inducible factor 1 alpha stabilization: a role for phosphatidylinositol 3′-kinase. Cancer Res. 62 (2002) 4469-4477
22. Kaluz S., Kaluzová M., and Stanbridge E.J. Proteasomal inhibition attenuates transcriptional activity of hypoxia-inducible factor 1 (HIF-1) via specific effect on the HIF-1alpha C-terminal activation domain. Mol. Cell. Biol. 26 (2006) 5895-5907
23. Sharma P.M., Egawa K., Huang Y., Martin J.L., Huvar I., Boss G.R., and Olefsky J.M. Inhibition of phosphatidylinositol 3-kinase activity by adenovirus-mediated gene transfer and its effect on insulin action. J. Biol. Chem. 273 (1998) 18528-18537
24. Kaluz S., Kaluzová M., and Stanbridge E.J. The role of extracellular signal-regulated protein kinase in transcriptional regulation of the hypoxia marker carbonic anhydrase IX. J. Cell. Biochem. 97 (2006) 207-216
25. Duronio V., Scheid M.P., and Ettinger S. Downstream signalling events regulated by phosphatidylinositol 3-kinase activity. Cell. Signal. 10 (1998) 233-239
26. Chan T.O., Rittenhouse S.E., and Tsichlis P.N. AKT/PKB and other D3 phosphoinositide-regulated kinases: kinase activation by phosphoinositide-dependent phosphorylation. Annu. Rev. Biochem. 68 (1999) 965-1014
27. Aoki M., Jiang H., and Vogt P.K. Proteasomal degradation of the FoxO1 transcriptional regulator in cells transformed by the PI3k and Akt oncoproteins. Proc. Natl. Acad. Sci. USA 101 (2004) 13613-13617
28. Jin H.O., An S., Lee H.C., Woo S.H., Seo S.K., Choe T.B., Yoo D.H., Lee S.B., Um H.D., Lee S.J., Park M.J., Kim J.I., Hong S.I., Rhee C.H., and Park I.C. Hypoxic condition- and high cell density-induced expression of Redd1 is regulated by activation of hypoxia-inducible factor-1alpha and Sp1 through the phosphatidylinositol 3-kinase/Akt signaling pathway. Cell Signal 19 (2007) 1393-1403
29. Lee B.L., Kim W.H., Jung J., Cho S.J., Park J.W., Kim J., Chung H.Y., Chang M.S., and Nam S.Y. A hypoxia-independent up-regulation of hypoxia-inducible factor-1 by AKT contributes to angiogenesis in human gastric cancer. Carcinogenesis 29 (2008) 44-51
30. Tanaka H., Yamamoto M., Hashimoto N., Miyakoshi M., Tamakawa S., Yoshie M., Tokusashi Y., Yokoyama K., Yaginuma Y., and Ogawa K. Hypoxia-independent overexpression of hypoxia-inducible factor 1alpha as an early change in mouse hepatocarcinogenesis. Cancer Res. 66 (2006) 11263-11270
31. Sheta E.A., Trout H., Gildea J.J., Harding M.A., and Theodorescu D. Cell density mediated pericellular hypoxia leads to induction of HIF-1alpha via nitric oxide and Ras/MAP kinase mediated signaling pathways. Oncogene 20 (2001) 7624-7634
32. Kaluzová M., Kaluz S., and Stanbridge E.J. High cell density induces expression from the carbonic anhydrase 9 promoter. Biotechniques 36 (2004) 228-230
33. Blancher C., Moore J.W., Robertson N., and Harris A.L. Effects of ras and von Hippel-Lindau (VHL) gene mutations on hypoxia-inducible factor (HIF)-1alpha, HIF-2alpha, and vascular endothelial growth factor expression and their regulation by the phosphatidylinositol 3'-kinase/Akt signaling pathway. Cancer Res. 61 (2001) 7349-7355
34. El-Osta A. DNMT cooperativity - the developing links between methylation, chromatin structure and cancer. Bioessays 25 (2003) 1071-1084
35. Raynaud F.I., Eccles S., Clarke P.A., Hayes A., Nutley B., Alix S., Henley A., Di-Stefano F., Ahmad Z., Guillard S., Bjerke L.M., Kelland L., Valenti M., Patterson L., Gowan S., de Haven Brandon A., Hayakawa M., Kaizawa H., Koizumi T., Ohishi T., Patel S., Saghir N., Parker P., Waterfield M., and Workman P. Pharmacologic characterization of a potent inhibitor of class I phosphatidylinositide 3-kinases. Cancer Res. 67 (2007) 5840-5850
36. Murphy D.J., Junttila M.R., Pouyet L., Karnezis A., Shchors K., Bui D.A., Brown-Swigart L., Johnson L., and Evan G.I. Distinct thresholds govern Myc's biological output in vivo. Cancer Cell 14 (2008) 447-457
37. Salceda S., and Caro J. Hypoxia-inducible factor 1alpha (HIF-1alpha) protein is rapidly degraded by the ubiquitin-proteasome system under normoxic conditions. J. Biol. Chem. 272 (1997) 22642-22647